BiotechTube
Home/SignaBlok/Alexander B. Sigalov, Ph.D.
AB

Alexander B. Sigalov, Ph.D.

Founder, President & CEO

SignaBlok

Therapeutic Areas

CancerAtherosclerosisAutoimmune DiseasesRetinopathyInflammatory DiseasesSepsis/ARDS

SignaBlok Pipeline

DrugIndicationPhase
Undisclosed SCHOOL-based programsCancer, Atherosclerosis, Autoimmune Diseases, Retinopathy, Inflammatory DiseasesPre-clinical